Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Top Cited Papers
Open Access
- 1 March 2009
- journal article
- other
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (3), 367-369
- https://doi.org/10.1016/j.bbmt.2008.12.497
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Reduced-Intensity Conditioning for Unrelated Donor Progenitor Cell Transplantation: Long-Term Follow-Up of the First 285 Reported to the National Marrow Donor ProgramTransplantation and Cellular Therapy, 2007
- Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensusBone Marrow Transplantation, 2004
- Aims of conditioningExperimental Hematology, 2003
- Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)Bone Marrow Transplantation, 2002
- Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?Leukemia, 2001
- Reduced intensity thiotepa–cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageBritish Journal of Haematology, 2000
- Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT)Bone Marrow Transplantation, 2000
- Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect.1999
- Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.1998
- Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Journal of Clinical Oncology, 1998